CN Patent
CN105769824A — 一种兰索拉唑缓释胶囊及其制备方法
Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2016-07-20 · 10y expired
What this patent protects
本发明属于医药技术领域,具体涉及一种右旋兰索拉唑缓释胶囊,该胶囊包含肠溶速释颗粒和肠溶缓释颗粒。在本发明的缓释胶囊中,使用了较少的碱性无机盐作为稳定剂,在保证右旋兰索拉唑稳定的前提下有效地提高了成品率,减少了损耗,从而降低了生产成本。本发明还提供了上述缓释胶囊的制备方法。
USPTO Abstract
本发明属于医药技术领域,具体涉及一种右旋兰索拉唑缓释胶囊,该胶囊包含肠溶速释颗粒和肠溶缓释颗粒。在本发明的缓释胶囊中,使用了较少的碱性无机盐作为稳定剂,在保证右旋兰索拉唑稳定的前提下有效地提高了成品率,减少了损耗,从而降低了生产成本。本发明还提供了上述缓释胶囊的制备方法。
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.